Stocktoria
NATIONAL HEALTHCARE CORP NHC
NATIONAL HEALTHCARE CORP financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.3B | $1.1B | $1.1B | $1.1B | $1.0B | $996.4M | $980.3M | $963.9M | $923.6M |
| Operating income | $128.4M | $89.9M | $57.5M | $31.9M | $50.9M | $48.2M | $49.0M | $56.1M | $54.1M | $60.5M |
| Interest expense | — | $4.1M | $324,000 | $563,000 | $845,000 | $1.4M | $3.1M | $4.7M | $4.9M | $3.9M |
| Income tax | $39.8M | $34.3M | $23.4M | $7.3M | $11.0M | $10.4M | $20.0M | $16.2M | $18.9M | $29.7M |
| Net income | $120.0M | $101.9M | $66.8M | $22.4M | $138.6M | $41.9M | $68.2M | $59.0M | $56.2M | $50.5M |
| EPS (diluted) | $7.67 | $6.53 | $4.34 | $1.45 | $8.99 | $2.72 | $4.44 | $3.87 | $3.69 | $3.32 |
| Operating cash flow | $185.1M | $107.3M | $111.2M | $8.7M | $62.4M | $203.3M | $100.1M | $98.4M | $94.5M | $90.9M |
| Free cash flow | $148.6M | $79.7M | $83.3M | -$21.5M | $23.0M | $181.4M | $73.7M | $68.7M | $62.1M | $28.3M |
| Cash & equivalents | $92.8M | $76.1M | $107.1M | $58.7M | $107.6M | $147.1M | $50.3M | $43.2M | $59.1M | $26.3M |
| Inventory | $7.8M | $9.0M | $7.4M | $7.1M | $8.6M | $8.8M | $7.4M | $7.5M | $7.2M | $7.5M |
| Total assets | $1.5B | $1.5B | $1.3B | $1.3B | $1.4B | $1.4B | $1.3B | $1.1B | $1.1B | $1.1B |
| Total liabilities | $451.9M | $541.3M | $400.3M | $397.9M | $494.9M | $563.9M | $507.6M | $346.5M | $393.1M | $417.8M |
| Shareholders' equity | $1.1B | $983.2M | $910.5M | $877.5M | $908.5M | $798.3M | $779.1M | $734.5M | $703.4M | $669.6M |
Growth · year-over-year · Revenue CAGR 5.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +16.1% | +14.5% | +5.1% | +1.1% | +4.5% | +3.2% | +1.6% | +1.7% | +4.4% | — |
| Net income growth | +17.7% | +52.6% | +197.6% | -83.8% | +231.0% | -38.6% | +15.7% | +4.9% | +11.2% | -4.9% |
| EPS growth | +17.5% | +50.5% | +199.3% | -83.9% | +230.5% | -38.7% | +14.7% | +4.9% | +11.1% | +3.7% |
| Free cash flow growth | +86.5% | -4.3% | — | -193.3% | -87.3% | +146.1% | +7.3% | +10.5% | +119.6% | +13.4% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.